Granules India appoints Ovais Sarmad as sustainability advisor Ruchika Sharma18 Nov 2024 2:53 PM ISTMumbai: Granules India Limited has announced that Ovais Sarmad has joined as an Advisor to the company. In this role, Sarmad will provide expert...
Granules India honoured with Golden Peacock Award for Sustainability Ruchika Sharma15 Nov 2024 11:00 AM ISTHyderabad: Granules India Limited, a pharmaceutical company, has announced that it has received the Golden Peacock Award for Sustainability....
Granules India Unit V facility receives USFDA EIR with 'No Action Indicated' status Ruchika Sharma8 Nov 2024 10:00 AM ISTHyderabad: Granules India Limited, a pharmaceutical manufacturing company, has announced that it has received an Establishment Inspection Report (EIR)...
Granules India appoints Ramraj Rangarajulu as President, Head of Formulations Operations MD Bureau17 Oct 2024 6:17 PM ISTNew Delhi: Granules India Limited has recently announced the appointment of Ramraj Rangarajulu as President and Head of Formulations Operations,...
Granules India unveils Mobile Cancer Screening Unit at AIG Hospitals Ruchika Sharma25 Sept 2024 2:19 PM ISTHyderabad: Granules India Ltd, a pharmaceutical company based in Hyderabad, has unveiled its Mobile Cancer Screening Unit at AIG Hospitals."This...
USFDA issues six observations for Granules India Gagillapur facility Ruchika Sharma7 Sept 2024 2:44 PM ISTHyderabad: Granules India Limited, has announced that the US Food and Drug Administration (USFDA) has concluded inspection at the Company's...
Granules India bags USFDA okay for Glycopyrrolate Oral Solution Ruchika Sharma20 Aug 2024 3:39 PM ISTHyderabad: Granules India has announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA)...
Major depressive disorder drug: USFDA nod to Granules India Trazodone Hydrochloride Tablets Ruchika Sharma9 Aug 2024 2:00 PM ISTHyderabad: Granules India Limited has announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug...
Granules India Promoter sells 3.09 pecent stake for Rs 304 crore Ruchika Sharma23 May 2024 12:47 PM ISTHyderabad: Krishna Prasad Chigurupati, a promoter of Granules India, has sold a 3.09 percent stake in the company for Rs 304 crore through an...
Granules India reports 1.6 percent fall in Q4 revenue Ruchika Sharma15 May 2024 4:52 PM ISTBengaluru: Granules India reported a 1.6% decrease in revenue for the fourth quarter on Wednesday, impacted by lower paracetamol sales and price...
Granules India arm gets USFDA nod for Gout flares drug Colchicine Ruchika Sharma30 April 2024 11:30 AM ISTColchicine Capsules are indicated for prophylaxis of gout flares in adults.
Granules India gets Zero 483's from USFDA for Unit V facility in AP Ruchika Sharma13 April 2024 12:08 PM ISTTelangana: Granules India has informed in a BSE filing that the Company's Unit V facility located at Anakapally, Visakhapatnam, Andhra ...
